Company Profile
ALX Oncology Stock Price, News & Analysis
- Ticker:
- ALXO
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, ALX Oncology is followed within the oncology universe where readouts and regulatory timing often dominate the stock.
Stock performance
1.76 USD (+7.98%)
Close
Last updated: June 23, 2026 at 00:00
236.83M USD
Market cap
Why the stock is moving
ALXO is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
ALX Oncology is an oncology-focused biopharmaceutical company centered on cancer programs, with investors watching clinical data, regulatory milestones, and the commercial path for its lead assets.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, ALX Oncology is followed within the oncology universe where readouts and regulatory timing often dominate the stock.
Business Model Characteristics
ALX Oncology follows a pipeline-and-commercial model where investors track trial execution, launch cadence, and the pace at which oncology data can be turned into durable product value.
Position Within the Biotechnology Landscape
Compared with larger diversified peers, ALX Oncology sits in a high-catalyst corner of the biotech landscape, where oncology updates can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
- 03
- 04
- 05
ALX Oncology to Present at the 44th Annual J.P. Morgan Healthcare Conference
Source: ALX Oncology
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of ALX Oncology (ALXO)?
ALX Oncology (ALXO) most recently closed at 1.76 USD, a +7.98% move versus the previous session.
What is the market cap of ALX Oncology (ALXO)?
ALX Oncology currently has a market capitalization of 236.83M USD on BioPharmSignal.
What does ALX Oncology do?
ALX Oncology is an oncology-focused biopharmaceutical company centered on cancer programs, with investors watching clinical data, regulatory milestones, and the commercial path for its lead assets.
On which exchange is ALXO stock listed?
ALX Oncology (ALXO) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, ALX Oncology is followed within the oncology universe where readouts and regulatory timing often dominate the stock., Biotechnology.
What is Oncology?
ALX Oncology is an oncology-focused biopharmaceutical company centered on cancer programs, with investors watching clinical data, regulatory milestones, and the commercial path for its lead assets.
Which conditions is ALX Oncology targeting with Oncology?
ALX Oncology is associated with oncology, cancer therapeutics based on its company overview and current catalyst commentary.